Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction

被引：5
作者：
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构：
[1] Clin Univ St Luc, Pole Rech Endocrinol Diabet & Nutr, Inst Rech Expt & Clin, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Lab Med, Brussels, Belgium
[4] Clin Univ St Luc, Div Cardiol, Brussels, Belgium
[5] Catholic Univ Louvain, Pole Rech Cardiovasc, Inst Rech Expt & Clin, Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2017年 / 248卷
关键词：
FGF; 23; NT-proBNP; ST2; Biomarker; Heart failure; Prognosis; EXPRESSION;
D O I：
10.1016/j.ijcard.2017.06.129
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：270 / 273
页数：4
相关论文
共 9 条
  • [1] Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study
    di Giuseppe, Romina
    Buijsse, Brian
    Hirche, Frank
    Wirth, Janine
    Arregui, Maria
    Westphal, Sabine
    Isermann, Berend
    Hense, Hans W.
    Dierkes, Jutta
    Boeing, Heiner
    Stangl, Gabriele I.
    Weikert, Cornelia
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (03) : 947 - 955
  • [2] Faul C., 2016, BONE, V16, P10
  • [3] Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients
    Gruson, Damien
    Ferracin, Benjamin
    Ahn, Sylvie A.
    Rousseau, Michel F.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 189 : 185 - 187
  • [4] Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro
    Li, GH
    Oparil, S
    Kelpke, SS
    Chen, YF
    Thompson, JA
    [J]. CIRCULATION, 2002, 106 (07) : 854 - 859
  • [5] Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
    Liu, SG
    Guo, R
    Simpson, LG
    Xiao, ZS
    Burnham, CE
    Quarles, LD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37419 - 37426
  • [6] Fibroblast Growth Factor-23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
    Lutsey, Pamela L.
    Alonso, Alvaro
    Selvin, Elizabeth
    Pankow, James S.
    Michos, Erin D.
    Agarwal, Sunil K.
    Loehr, Laura R.
    Eckfeldt, John H.
    Coresh, Josef
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (03):
  • [7] Fibroblast Growth Factor-23 and Incident Atrial Fibrillation The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)
    Mathew, Jehu S.
    Sachs, Michael C.
    Katz, Ronit
    Patton, Kristen K.
    Heckbert, Susan R.
    Hoofnagle, Andrew N.
    Alonso, Alvaro
    Chonchol, Michel
    Deo, Rajat
    Ix, Joachim H.
    Siscovick, David S.
    Kestenbaum, Bryan
    de Boer, Ian H.
    [J]. CIRCULATION, 2014, 130 (04) : 298 - U40
  • [8] Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
    Wohlfahrt, Peter
    Melenovsky, Vojtech
    Kotrc, Martin
    Benes, Jan
    Jabor, Antonin
    Franekova, Janka
    Lemaire, Sophia
    Kautzner, Josef
    Jarolim, Petr
    [J]. JACC-HEART FAILURE, 2015, 3 (10) : 829 - 839
  • [9] Zittermann A., 2016, NUTR METAB CARDIOVAS, V16, P10
1